Omega Healthcare Investors financials
$46.54−0.30%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.00B | $887.9M | $826.4M | $875.1M | $1.06B | $888.7M | $805.1M | $769.0M | $807.5M | $806.2M |
| Gross profit | $1.00B | $887.9M | $826.4M | $875.1M | $1.06B | $888.7M | $805.1M | $769.0M | $807.5M | $806.2M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $542.0M | $467.0M | $271.8M | $353.8M | $521.2M | $380.8M | $376.1M | $362.3M | $165.8M | $418.1M |
| Net income | $572.0M | $406.3M | $242.2M | $426.9M | $416.7M | $159.3M | $341.1M | $281.6M | $100.4M | $366.4M |
| Net margin | 57.1% | 45.8% | 29.3% | 48.8% | 39.3% | 17.9% | 42.4% | 36.6% | 12.4% | 45.5% |
| Diluted EPS | $1.94 | $1.55 | $1.00 | $1.80 | $1.75 | $0.70 | $1.58 | $1.40 | $0.51 | $1.90 |
| EBITDA | $894.1M | $807.1M | $688.8M | $719.0M | $898.4M | $771.1M | $730.2M | $690.2M | $738.8M | $739.5M |
| Operating cash flow | $878.6M | $749.4M | $617.7M | $625.7M | $722.1M | $708.3M | $553.7M | $499.4M | $577.9M | $624.8M |
| Free cash flow | $81.1M | $234.1M | $272.8M | $331.4M | -$33.7M | $496.4M | -$16.7M | $225.0M | $68.0M | $515.3M |
| Diluted shares | 305.0M | 270.5M | 250.5M | 244.3M | 244.3M | 235.1M | 222.1M | 209.7M | 206.8M | 201.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $27.0M | $518.3M | $442.8M | $297.1M | $20.5M | $163.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $10.9M | $10.8M |
| Total debt | $4.26B | $4.84B | $5.07B | $5.29B | $5.25B | $5.17B |
| Total assets | $10.05B | $9.90B | $9.12B | $9.41B | $9.64B | $9.50B |
| Total liabilities | $4.61B | $5.17B | $5.36B | $5.60B | $5.53B | $5.46B |
| Shareholders' equity | $5.44B | $4.73B | $3.76B | $3.80B | $4.11B | $4.04B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology